The Tryptophan Catabolite or Kynurenine Pathway in COVID-19 and Critical COVID-19: a Systematic Review and Meta-analysis

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2022 Jul 15

PMID 35840908

Authors

Abbas F Almulla

Thitiporn Supasitthumrong

Chavit Tunvirachaisakul

Ali Abbas Abo Algon

Hussein K Al-Hakeim

Michael Maes

Affiliations

Soon will be listed here.

Abstract

Background: Coronavirus disease 2019 (COVID-19) is accompanied by activated immune-inflammatory pathways and oxidative stress, which both induce indoleamine-2,3-dioxygenase (IDO), a key enzyme of the tryptophan (TRP) catabolite (TRYCAT) pathway. The aim of this study was to systematically review and meta-analyze the status of the TRYCAT pathway, including the levels of TRP and kynurenine (KYN) and the activity of IDO, as measured by the ratio of KYN/TRP.

Methods: This systematic review searched PubMed, Google Scholar, and Web of Sciences and included 14 articles that compared TRP and tryptophan catabolites (TRYCATs) in COVID-19 patients versus non-COVID-19 controls, as well as severe/critical versus mild/moderate COVID-19. The analysis was done on a total of 1269 people, including 794 COVID-19 patients and 475 controls.

Results: The results show a significant (p < 0.0001) increase in the KYN/TRP ratio (standardized mean difference, SMD = 1.099, 95% confidence interval, CI: 0.714; 1.484) and KYN (SMD = 1.123, 95% CI: 0.730; 1.516) and significantly lower TRP (SMD = - 1.002, 95%CI: - 1.738; - 0.266) in COVID-19 versus controls. The KYN/TRP ratio (SMD = 0.945, 95%CI: 0.629; 1.262) and KYN (SMD = 0.806, 95%CI: 0.462; 1.149) were also significantly (p < 0.0001) higher and TRP lower (SMD = - 0.909, 95% CI: - 1.569; - 0.249) in severe/critical versus mild/moderate COVID-19. No significant difference was detected in kynurenic acid (KA) and the KA/KYN ratio between COVID-19 patients and controls.

Conclusions: Our results indicate increased activity of the IDO enzyme in COVID-19 and severe/critical patients. The TRYCAT pathway is implicated in the pathophysiology and progression of COVID-19 and may signal a worsening outcome of the disease.

Citing Articles

Longitudinal Metabolomics Reveals Metabolic Dysregulation Dynamics in Patients with Severe COVID-19.

Uchimido R, Kami K, Yamamoto H, Yokoe R, Tsuchiya I, Nukui Y Metabolites. 2024; 14(12).

PMID: 39728437 PMC: 11676849. DOI: 10.3390/metabo14120656.

Dysrupted microbial tryptophan metabolism associates with SARS-CoV-2 acute inflammatory responses and long COVID.

Yao L, Devotta H, Li J, Lunjani N, Sadlier C, Lavelle A Gut Microbes. 2024; 16(1):2429754.

PMID: 39551951 PMC: 11581176. DOI: 10.1080/19490976.2024.2429754.

The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects.

Alves L, Moore J, Kell D Int J Mol Sci. 2024; 25(16).

PMID: 39201768 PMC: 11354673. DOI: 10.3390/ijms25169082.

Laboratory parameters related to disease severity and physical performance after reconvalescence of acute COVID-19 infection.

Gietl M, Burkert F, Hofer S, Gostner J, Sonnweber T, Tancevski I Sci Rep. 2024; 14(1):10388.

PMID: 38710760 PMC: 11074335. DOI: 10.1038/s41598-024-57448-6.

Significance of nitrosative stress and glycoxidation products in the diagnosis of COVID-19.

Wolszczak-Biedrzycka B, Dorf J, Matowicka-Karna J, Wojewodzka-Zelezniakowicz M, Zukowski P, Zalewska A Sci Rep. 2024; 14(1):9198.

PMID: 38649417 PMC: 11035544. DOI: 10.1038/s41598-024-59876-w.

References

Reyes Ocampo J, Lugo Huitron R, Gonzalez-Esquivel D, Ugalde-Muniz P, Jimenez-Anguiano A, Pineda B . Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. Oxid Med Cell Longev. 2014; 2014:646909. PMC: 3945746. DOI: 10.1155/2014/646909. View

Maes M, Anderson G . False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes. Front Psychiatry. 2021; 12:663985. PMC: 8245788. DOI: 10.3389/fpsyt.2021.663985. View

DAmora P, Silva I, Budib M, Ayache R, Silva R, Silva F . Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection. PLoS One. 2021; 16(12):e0259909. PMC: 8635335. DOI: 10.1371/journal.pone.0259909. View

Coomes E, Haghbayan H . Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev Med Virol. 2020; 30(6):1-9. PMC: 7460877. DOI: 10.1002/rmv.2141. View

Ormstad H, Verkerk R, Amthor K, Sandvik L . Activation of the kynurenine pathway in the acute phase of stroke and its role in fatigue and depression following stroke. J Mol Neurosci. 2014; 54(2):181-7. DOI: 10.1007/s12031-014-0272-0. View

Fraser D, Slessarev M, Martin C, Daley M, Patel M, Miller M . Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers. Crit Care Explor. 2020; 2(10):e0272. PMC: 7587450. DOI: 10.1097/CCE.0000000000000272. View

Smith R, Maes M . The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses. 1995; 45(2):135-41. DOI: 10.1016/0306-9877(95)90062-4. View

Rahman A, Rao M, Khan K . Intraventricular infusion of quinolinic acid impairs spatial learning and memory in young rats: a novel mechanism of lead-induced neurotoxicity. J Neuroinflammation. 2018; 15(1):263. PMC: 6137743. DOI: 10.1186/s12974-018-1306-2. View

Almulla A, Supasitthumrong T, Amrapala A, Tunvirachaisakul C, Abdul Jaleel A, Oxenkrug G . The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2022; 88(4):1325-1339. DOI: 10.3233/JAD-220295. View

10.

Taquet M, Geddes J, Husain M, Luciano S, Harrison P . 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8(5):416-427. PMC: 8023694. DOI: 10.1016/S2215-0366(21)00084-5. View

11.

Almulla A, Vasupanrajit A, Tunvirachaisakul C, Al-Hakeim H, Solmi M, Verkerk R . The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments. Mol Psychiatry. 2022; 27(9):3679-3691. DOI: 10.1038/s41380-022-01552-4. View

12.

Vasupanrajit A, Jirakran K, Tunvirachaisakul C, Solmi M, Maes M . Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis. Mol Psychiatry. 2022; 27(3):1350-1361. DOI: 10.1038/s41380-021-01407-4. View

13.

Almulla A, Maes M . The Tryptophan Catabolite or Kynurenine Pathway's Role in Major Depression. Curr Top Med Chem. 2022; 22(21):1731-1735. DOI: 10.2174/1568026622666220428095250. View

14.

Andres-Rodriguez L, Borras X, Feliu-Soler A, Perez-Aranda A, Angarita-Osorio N, Moreno-Peral P . Peripheral immune aberrations in fibromyalgia: A systematic review, meta-analysis and meta-regression. Brain Behav Immun. 2019; 87:881-889. DOI: 10.1016/j.bbi.2019.12.020. View

15.

Abedi S, Vessal M, Asadian F, Takhshid M . Association of serum kynurenine/tryptophan ratio with poor glycemic control in patients with type2 diabetes. J Diabetes Metab Disord. 2021; 20(2):1521-1527. PMC: 8630152. DOI: 10.1007/s40200-021-00895-z. View

16.

Sagulkoo P, Plaimas K, Suratanee A, Simao A, Reiche E, Maes M . Immunopathogenesis and Immunogenetic Variants in COVID-19. Curr Pharm Des. 2022; 28(22):1780-1797. DOI: 10.2174/1381612828666220519150821. View

17.

Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A . T cell apoptosis by tryptophan catabolism. Cell Death Differ. 2002; 9(10):1069-77. DOI: 10.1038/sj.cdd.4401073. View

18.

Al Saedi A, Sharma S, Summers M, Nurgali K, Duque G . The multiple faces of tryptophan in bone biology. Exp Gerontol. 2019; 129:110778. DOI: 10.1016/j.exger.2019.110778. View

19.

Goldstein L, Leopold M, Huang X, Atwood C, Saunders A, Hartshorn M . 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry. 2000; 39(24):7266-75. DOI: 10.1021/bi992997s. View

20.

Maes M, Leonard B, Myint A, Kubera M, Verkerk R . The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute.... Prog Neuropsychopharmacol Biol Psychiatry. 2010; 35(3):702-21. DOI: 10.1016/j.pnpbp.2010.12.017. View